Moderna announces expansion of BARDA agreement to support larger phase 3 programme for Covid-19 vaccine

This article was originally published here

An earlier award from BARDA for up to $483 million was entered into to support the scale up of mRNA-1273 and clinical development, originally with a smaller anticipated

The post Moderna announces expansion of BARDA agreement to support larger phase 3 programme for Covid-19 vaccine appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply